233 related articles for article (PubMed ID: 28559023)
41. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Xu Y; Zhang M; Yue Q; Zong J; Lin J; Sun R; Qiu S; Lin S; Pan J
Cancer Radiother; 2016 Jul; 20(5):377-83. PubMed ID: 27372558
[TBL] [Abstract][Full Text] [Related]
42. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging.
Tang L; Mao Y; Liu L; Liang S; Chen Y; Sun Y; Liao X; Lin A; Liu M; Li L; Ma J
Cancer; 2009 Feb; 115(3):680-8. PubMed ID: 19117352
[TBL] [Abstract][Full Text] [Related]
43. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.
Hung TM; Chen CC; Lin CY; Ng SH; Kang CJ; Huang SF; Liao CT; Fan KH; Wang HM; Chang JT
Oral Oncol; 2014 Mar; 50(3):228-33. PubMed ID: 24394562
[TBL] [Abstract][Full Text] [Related]
45. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
[TBL] [Abstract][Full Text] [Related]
46. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
47. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
Chow E; Payne D; Keane T; Panzarella T; Izard MA
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
[TBL] [Abstract][Full Text] [Related]
48. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging.
Mao YP; Liang SB; Liu LZ; Chen Y; Sun Y; Tang LL; Tian L; Lin AH; Liu MZ; Li L; Ma J
Clin Cancer Res; 2008 Nov; 14(22):7497-503. PubMed ID: 19010867
[TBL] [Abstract][Full Text] [Related]
49. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
You R; Sun R; Hua YJ; Li CF; Li JB; Zou X; Yang Q; Liu YP; Zhang YN; Yu T; Cao JY; Zhang MX; Jiang R; Mo HY; Guo L; Cao KJ; Lin AH; Qian CN; Sun Y; Ma J; Chen MY
Int J Cancer; 2017 Sep; 141(6):1265-1276. PubMed ID: 28577306
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Value of Cervical Nodal Necrosis in Nasopharyngeal Carcinoma: Analysis of 1800 Patients with Positive Cervical Nodal Metastasis at MR Imaging.
Lan M; Huang Y; Chen CY; Han F; Wu SX; Tian L; Zheng L; Lu TX
Radiology; 2015 Aug; 276(2):536-44. PubMed ID: 25759968
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy.
Wang M; Xu Y; Chen X; Chen H; Gong H; Chen S
J Cancer Res Ther; 2016; 12(2):909-14. PubMed ID: 27461673
[TBL] [Abstract][Full Text] [Related]
52. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
[TBL] [Abstract][Full Text] [Related]
53. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
54. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY
Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027
[TBL] [Abstract][Full Text] [Related]
55. Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes.
Xiao F; Dou S; Li Y; Qian W; Liang F; Kong L; Wang X; Wu K; Hu C; Zhu G
Clin Transl Oncol; 2019 Jun; 21(6):781-789. PubMed ID: 30515646
[TBL] [Abstract][Full Text] [Related]
56. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.
Chen L; Liu LZ; Chen M; Li WF; Yin WJ; Lin AH; Sun Y; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):196-202. PubMed ID: 22300569
[TBL] [Abstract][Full Text] [Related]
58. Additional Cervical Lymph Node Biopsy is Not a Significant Prognostic Factor for Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era: A Propensity Score-matched Analysis from an Epidemic Area.
Yang XL; Wang Y; Bao Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
J Cancer; 2018; 9(16):2844-2851. PubMed ID: 30123353
[No Abstract] [Full Text] [Related]
59. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
60. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
